Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a dupilumab study in pediatric atopic dermatitis
2014-003263-37Phase 2Completed
- Sponsor
- Regeneron Pharmaceuticals
- Start
- Dec 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of dupilumab in atopic dermatitis (AD) (2 arms), sponsored by Regeneron Pharmaceuticals. Started Dec 2014; status: completed.
02
Drugs
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2014-003263-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003263-37.